SeqWell
PrivateLast Round
Seed Round
Sep 1, 2026
Total Funding Raised
$24.52M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SeqWell operates in Healthcare & Life Sciences and is based in Beverly, Massachusetts. Its latest recorded funding round was a Series C Extension round in February 2025.
SeqWell is a biotechnology company that develops and provides next-generation sequencing (NGS) library preparation technologies and kits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SeqWell Comparables
Compare SeqWell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paragon Genomics | 86% | |
| Jumpcode Genomics | 81% | |
| Watchmaker Genomics | 80% |
For institutional investors. Book with your work email.
SeqWell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 1, 2026 | ||||
| Series C Extension | Feb 6, 2025 | ||||
| Early Funding | Jan 15, 2025 | ||||
| Series C Extension | Sep 11, 2023 | ||||
| Series C | Apr 21, 2022 | ||||
Series B | Jan 14, 2020 |
For institutional investors. Book with your work email.
SeqWell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Series C, Series B |
| BroadOak Capital Partners | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
$960K raised in Seed Round.
- Jun 21, 2026
Monthly visitors increased 46% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- licenses_technologyOct 16, 2026
New England Biolabs, Inc. secures co-exclusive rights from seqWell, Inc. to sell TnX Transposase (Unloaded), manufacture the enzyme, and include it in kits and products in New York on Oct 16th '26.
For institutional investors. Book with your work email.
SeqWell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SeqWell's valuation, stock price, and market status.
Is SeqWell a public or private company?
SeqWell is a private company.
What is the current stock price of SeqWell?
SeqWell is a private company, so its shares have no public market price. Caplight tracks SeqWell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SeqWell worth (valuation)?
Valuation information for SeqWell is not publicly available.
Can I buy SeqWell stock?
SeqWell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SeqWell's last funding round?
SeqWell's most recent funding round was Seed Round on September 1, 2026.
Who are the main investors in SeqWell?
Key investors in SeqWell include Research Corporation Technologies.
Will SeqWell IPO soon?
No public IPO plans have been announced for SeqWell.
How can I track SeqWell secondary market activity?
Caplight tracks bids, offers, and trades in SeqWell's shares on secondary markets.